Nebulizers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Nebulizer is a device which helps in direct delivery of medicine in case of respiratory disorders. The nebulizer pipeline market research report provides key information and data related to extensive coverage of the nebulizer under development. It also gives review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates. It also provides review of major players involved in the pipeline product development. The report provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major nebulizer pipeline products. Again, the report gives review of recent developments in the segment/industry.

Which are the key segments in the nebulizer pipeline market?

The key segments in the nebulizer pipeline market are vibrating mesh nebulizers, ultrasonic nebulizers, and compressor nebulizers. Vibrating mesh nebulizers is the largest segment in the nebulizer pipeline market.

Nebulizer pipeline market, by segments

Nebulizer pipeline market, by segments

For more segment insights, download a free sample

Which are the key territories in the nebulizer pipeline market?

The key territories in the nebulizer pipeline market are the United States, Canada, Europe, Australia, New Zealand, and China. The US had the highest number of pipeline products in the nebulizer pipeline market.

Nebulizer pipeline market, by territories

Nebulizer pipeline market, by territories

For more territory insights, download a free sample

Which are the key regulatory paths in the nebulizer pipeline market?

The key regulatory paths in the nebulizer pipeline market are 510(k), CE, MDL, TGA, and NMPA. 510(k) had the highest number of pipeline products in the nebulizer pipeline market.

Nebulizer pipeline market, by regulatory paths

Nebulizer pipeline market, by regulatory paths

For more regulatory path insights, download a free sample

Which are the key companies in the nebulizer pipeline market?

The key companies in the nebulizer pipeline market are Ablynx NV, Aeon Research & Technology, AFT Pharmaceuticals Ltd, Aura Medical, Baby’s Breath Ltd, Bridgesource Medical Corp, Creare LLC, DesignWise Medical Inc (Inactive), HCmed Innovations Co Ltd, Marquette University, Omron Healthcare Co Ltd, Omron Healthcare Inc, PARI GmbH, Parion Sciences Inc, Respira Technologies Inc, RMIT University, SolAeroMed Inc, Stirling Pharma Inc, Teleflex Inc, University of California San Diego, University of Texas Medical Branch at Galveston, Verona Pharma Plc, Vincent Medical Holdings Ltd, and Wellinks Inc.

Market report scope

Key territories The United States, Canada, Europe, Australia, New Zealand, and China
Key segments Vibrating Mesh Nebulizers, Ultrasonic Nebulizers, and Compressor Nebulizers
Key regulatory paths 510(k), CE, MDL, TGA, and NMPA
Key companies Ablynx NV, Aeon Research & Technology, AFT Pharmaceuticals Ltd, Aura Medical, Baby’s Breath Ltd, Bridgesource Medical Corp, Creare LLC, DesignWise Medical Inc (Inactive), HCmed Innovations Co Ltd, Marquette University, Omron Healthcare Co Ltd, Omron Healthcare Inc, PARI GmbH, Parion Sciences Inc, Respira Technologies Inc, RMIT University, SolAeroMed Inc, Stirling Pharma Inc, Teleflex Inc, University of California San Diego, University of Texas Medical Branch at Galveston, Verona Pharma Plc, Vincent Medical Holdings Ltd, and Wellinks Inc

Scope

  • Extensive coverage of the nebulizer under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of nebulizer and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from early development to approved / issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of nebulizers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Ablynx NV
Aeon Research & Technology
AFT Pharmaceuticals Ltd
Aura Medical
Baby's Breath Ltd
Bridgesource Medical Corp
Creare LLC
DesignWise Medical Inc (Inactive)
HCmed Innovations Co Ltd
Marquette University
Omron Healthcare Co Ltd
Omron Healthcare Inc
PARI GmbH
Parion Sciences Inc
Respira Technologies Inc
RMIT University
SolAeroMed Inc
Stirling Pharma Inc
Teleflex Inc
University of California San Diego
University of Texas Medical Branch at Galveston
Verona Pharma Plc
Vincent Medical Holdings Ltd
Wellinks Inc

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 7

2 Introduction 8

2.1 Nebulizers Overview 8

3 Products under Development 9

3.1 Nebulizers – Pipeline Products by Stage of Development 9

3.2 Nebulizers – Pipeline Products by Segment 10

3.3 Nebulizers – Pipeline Products by Territory 11

3.4 Nebulizers – Pipeline Products by Regulatory Path 12

3.5 Nebulizers – Pipeline Products by Estimated Approval Date 13

3.6 Nebulizers – Ongoing Clinical Trials 14

4 Nebulizers – Pipeline Products under Development by Companies 15

4.1 Nebulizers Companies – Pipeline Products by Stage of Development 15

4.2 Nebulizers – Pipeline Products by Stage of Development 16

5 Nebulizers Companies and Product Overview 17

5.1 Ablynx NV Company Overview 17

5.1.1 Ablynx NV Pipeline Products & Ongoing Clinical Trials Overview 17

5.2 Aeon Research & Technology Company Overview 18

5.2.1 Aeon Research & Technology Pipeline Products & Ongoing Clinical Trials Overview 18

5.3 AFT Pharmaceuticals Ltd Company Overview 19

5.3.1 AFT Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview 19

5.4 Aura Medical Company Overview 20

5.4.1 Aura Medical Pipeline Products & Ongoing Clinical Trials Overview 20

5.5 Baby’s Breath Ltd Company Overview 21

5.5.1 Baby’s Breath Ltd Pipeline Products & Ongoing Clinical Trials Overview 21

5.6 Bridgesource Medical Corp Company Overview 22

5.6.1 Bridgesource Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 22

5.7 Creare LLC Company Overview 23

5.7.1 Creare LLC Pipeline Products & Ongoing Clinical Trials Overview 23

5.8 DesignWise Medical Inc (Inactive) Company Overview 24

5.8.1 DesignWise Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 24

5.9 HCmed Innovations Co Ltd Company Overview 25

5.9.1 HCmed Innovations Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 25

5.10 Marquette University Company Overview 26

5.10.1 Marquette University Pipeline Products & Ongoing Clinical Trials Overview 26

5.11 Omron Healthcare Co Ltd Company Overview 27

5.11.1 Omron Healthcare Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 27

5.12 Omron Healthcare Inc Company Overview 28

5.12.1 Omron Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.13 PARI GmbH Company Overview 29

5.13.1 PARI GmbH Pipeline Products & Ongoing Clinical Trials Overview 29

5.14 Parion Sciences Inc Company Overview 30

5.14.1 Parion Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 30

5.15 Respira Technologies Inc Company Overview 31

5.15.1 Respira Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 31

5.16 RMIT University Company Overview 32

5.16.1 RMIT University Pipeline Products & Ongoing Clinical Trials Overview 32

5.17 SolAeroMed Inc Company Overview 33

5.17.1 SolAeroMed Inc Pipeline Products & Ongoing Clinical Trials Overview 33

5.18 Stirling Pharma Inc Company Overview 34

5.18.1 Stirling Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview 34

5.19 Teleflex Inc Company Overview 35

5.19.1 Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 35

5.20 University of California San Diego Company Overview 36

5.20.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 36

5.21 University of Texas Medical Branch at Galveston Company Overview 37

5.21.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 37

5.22 Verona Pharma Plc Company Overview 38

5.22.1 Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview 38

5.23 Vincent Medical Holdings Ltd Company Overview 41

5.23.1 Vincent Medical Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 41

5.24 Wellinks Inc Company Overview 42

5.24.1 Wellinks Inc Pipeline Products & Ongoing Clinical Trials Overview 42

6 Nebulizers- Recent Developments 43

6.1 Feb 24, 2022: Teleflex Announces Fourth Quarter and Full-Year 2021 Financial Results 43

6.2 Feb 24, 2022: United Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results 44

6.3 Feb 21, 2022: United Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results Before the Market Opens on Thursday, February 24, 2022 49

6.4 Feb 03, 2022: Cardinal Health Reports Second Quarter Fiscal 2022 Results 50

6.5 Dec 30, 2021: United Therapeutics to Webcast Executive Fireside Chat Conversation With J.P. Morgan Analyst 51

6.6 Nov 29, 2021: Owens & Minor to Present at Bank of America Leveraged Finance Conference 51

6.7 Nov 18, 2021: Teleflex to Participate in the 33rd Annual Virtual Piper Sandler Healthcare Conference 51

6.8 Nov 09, 2021: Cardinal Health Reports First Quarter Fiscal 2022 Results 52

6.9 Nov 03, 2021: United Therapeutics Reports Third Quarter 2021 Financial Results 53

6.10 Nov 01, 2021: United Therapeutics To Present At The Credit Suisse 30th Annual Healthcare Conference 54

6.11 Nov 01, 2021: United Therapeutics Corporation To Present At The Credit Suisse 30th Annual Healthcare Conference 55

6.12 Oct 28, 2021: Teleflex Reports Third Quarter 2021 Results and Full Year Outlook 55

6.13 Oct 21, 2021: Owens & Minor will Report Third Quarter Financial Results on Wednesday, November 3, 2021 59

6.14 Oct 14, 2021: Teleflex Announces Third Quarter 2021 Earnings Conference Call Information 59

6.15 Sep 22, 2021: GBLT receives €2.1m order from Europe’s largest retailer for new products 59

6.16 Sep 01, 2021: Teleflex to Present at the Morgan Stanley 19th Annual Global Healthcare Conference 60

6.17 Aug 26, 2021: Teleflex to Present at the Wells Fargo 2021 Virtual Healthcare Conference 60

6.18 Aug 05, 2021: Cardinal Health reports fourth quarter and full year results for fiscal year 2021 60

6.19 Aug 04, 2021: United Therapeutics Reports Second Quarter 2021 Financial Results 62

6.20 Aug 03, 2021: Nanoform and Boehringer Ingelheim execute master services agreement 63

6.21 Aug 03, 2021: United Therapeutics To Present At The 2021 Wedbush PacGrow Healthcare Virtual Conference 63

6.22 Jul 28, 2021: United Therapeutics To Report Second Quarter 2021 Financial Results Before The Market Opens On Wednesday, August 4, 2021 63

6.23 Jul 20, 2021: Owens & Minor will Report Second Quarter Financial Results on Tuesday, August 3, 2021 64

6.24 Jun 22, 2021: Dr. Stefan Seemann is appointed President of PARI Pharma 64

6.25 Jun 02, 2021: Shanghai Asclepius Meditec and International Department of Central Committee of CPC collaborate to provide emergency support to fight COVID-19 in Nepal 65

6.26 May 27, 2021: Vectura Group announce Directorate Change 66

6.27 May 06, 2021: Cardinal Health reports third-quarter results for fiscal year 2021 66

6.28 May 05, 2021: United Therapeutics Reports First Quarter 2021 Financial Results 67

6.29 May 05, 2021: Owens & Minor Reports 1st Quarter Financial Results 68

6.30 Apr 29, 2021: Teleflex Reports First Quarter 2021 Results 69

6.31 Apr 26, 2021: United Therapeutics To Report First Quarter 2021 Financial Results Before The Market Opens On Wednesday, May 5, 2021 73

6.32 Apr 23, 2021: Vectura Group announce 2020 Annual Report, 2021 AGM notice & GM circular 74

6.33 Apr 22, 2021: Owens & Minor will Report First Quarter Financial Results on Wednesday, May 5, 2021 74

6.34 Mar 18, 2021: Vectura Group Announces 2020 Preliminary Results 75

7 Appendix 76

7.1 Methodology 76

7.2 About GlobalData 79

7.3 Contact Us 79

7.4 Disclaimer 79

Table

Nebulizers – Pipeline Products by Stage of Development 9

Nebulizers – Pipeline Products by Segment 10

Nebulizers – Pipeline Products by Territory 11

Nebulizers – Pipeline Products by Regulatory Path 12

Nebulizers – Pipeline Products by Estimated Approval Date 13

Nebulizers – Ongoing Clinical Trials 14

Nebulizers Companies – Pipeline Products by Stage of Development 15

Nebulizers – Pipeline Products by Stage of Development 16

Ablynx NV Pipeline Products & Ongoing Clinical Trials Overview 17

Customised Infant Inhalation Device – Product Status 17

Customised Infant Inhalation Device – Product Description 17

Aeon Research & Technology Pipeline Products & Ongoing Clinical Trials Overview 18

LYNX Nebulizer – Product Status 18

LYNX Nebulizer – Product Description 18

AFT Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview 19

NasoSURF – Product Status 19

NasoSURF – Product Description 19

Aura Medical Pipeline Products & Ongoing Clinical Trials Overview 20

Nebican – Product Status 20

Nebican – Product Description 20

Baby’s Breath Ltd Pipeline Products & Ongoing Clinical Trials Overview 21

WiseAir – Product Status 21

WiseAir – Product Description 21

Bridgesource Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 22

Breath-Adaptive Nebulizer – Product Status 22

Breath-Adaptive Nebulizer – Product Description 22

Creare LLC Pipeline Products & Ongoing Clinical Trials Overview 23

DDC-Based Nebulizer – Product Status 23

DDC-Based Nebulizer – Product Description 23

DesignWise Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 24

Self-Contained Nebulizer System – Product Status 24

Self-Contained Nebulizer System – Product Description 24

HCmed Innovations Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 25

AdheResp – Product Status 25

AdheResp – Product Description 25

Marquette University Pipeline Products & Ongoing Clinical Trials Overview 26

Human Powered Nebulizer – Product Status 26

Human Powered Nebulizer – Product Description 26

Omron Healthcare Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 27

Avt – Product Status 27

Avt – Product Description 27

Omron Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 28

Neko Cat – Product Status 28

Neko Cat – Product Description 28

PARI GmbH Pipeline Products & Ongoing Clinical Trials Overview 29

Vibrating Mesh Nebulizer For RespiraClear – Product Status 29

Vibrating Mesh Nebulizer For RespiraClear – Product Description 29

Parion Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 30

tPAD Device – Product Status 30

tPAD Device – Product Description 30

Respira Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 31

RespiRx – Nicotine Replacement Therapy (NRT) – Product Status 31

RespiRx – Nicotine Replacement Therapy (NRT) – Product Description 31

RMIT University Pipeline Products & Ongoing Clinical Trials Overview 32

UAS Nebulizer – Product Status 32

UAS Nebulizer – Product Description 32

SolAeroMed Inc Pipeline Products & Ongoing Clinical Trials Overview 33

S1226 Neublizer System – Product Status 33

S1226 Neublizer System – Product Description 33

Stirling Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview 34

High Density Aerosol Drug Delivery Device – Product Status 34

High Density Aerosol Drug Delivery Device – Product Description 34

Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 35

Turbomist – Product Status 35

Turbomist – Product Description 35

University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 36

Nebulizer – Product Status 36

Nebulizer – Product Description 36

University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 37

Pulse Drug Nebulization System – Product Status 37

Pulse Drug Nebulization System – Product Description 37

Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview 38

RPL554 Nebulizer – Product Status 38

RPL554 Nebulizer – Product Description 38

Verona Pharma Plc – Ongoing Clinical Trials Overview 39

RPL554 Nebulizer – A Phase III Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ensifentrine over 24 weeks (with a 48-week Safety Subset) in Subjects with Moderate to Severe COPD 40

RPL554 Nebulizer – A Phase III Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ensifentrine over 24 Weeks in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease 40

Vincent Medical Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 41

Home Use Ultrasonic Nebulizer – Product Status 41

Home Use Ultrasonic Nebulizer – Product Description 41

Wellinks Inc Pipeline Products & Ongoing Clinical Trials Overview 42

Bluetooth Enabled Flyp Nebulizer – Product Status 42

Bluetooth Enabled Flyp Nebulizer – Product Description 42

Glossary 78

Figures

Nebulizers – Pipeline Products by Stage of Development 9

Nebulizers – Pipeline Products by Segment 10

Nebulizers – Pipeline Products by Territory 11

Nebulizers – Pipeline Products by Regulatory Path 12

Nebulizers – Pipeline Products by Estimated Approval Date 13

Nebulizers – Ongoing Clinical Trials 14

Frequently asked questions

  • Which are the key segments in the nebulizer market?

    The key segments in the nebulizer pipeline market are vibrating mesh nebulizers, ultrasonic nebulizers, and compressor nebulizers. Vibrating mesh nebulizers is the largest segment in the nebulizer pipeline market.

  • Which are the key territories in the nebulizer market?

    The key territories in the nebulizer pipeline market are the United States, Canada, Europe, Australia, New Zealand, and China. The US had the highest number of pipeline products in the Nebulizer pipeline market.

  • Which are the key regulatory paths in the nebulizer market?

    The key regulatory paths in the nebulizer pipeline market are 510(k), CE, MDL, TGA, and NMPA. 510(k) had the highest number of pipeline products in the Nebulizer pipeline market.

  • Which are the key companies in the nebulizer market?

    The key companies in the nebulizer pipeline market are Ablynx NV, Aeon Research & Technology, AFT Pharmaceuticals Ltd, Aura Medical, Baby’s Breath Ltd, Bridgesource Medical Corp, Creare LLC, DesignWise Medical Inc (Inactive), HCmed Innovations Co Ltd, Marquette University, Omron Healthcare Co Ltd, Omron Healthcare Inc, PARI GmbH, Parion Sciences Inc, Respira Technologies Inc, RMIT University, SolAeroMed Inc, Stirling Pharma Inc, Teleflex Inc, University of California San Diego, University of Texas Medical Branch at Galveston, Verona Pharma Plc, Vincent Medical Holdings Ltd, and Wellinks Inc.

Nebulizers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 standard reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Nebulizers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Nebulizers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 in real time.

  • Access a live Nebulizers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.